Qualigen Therapeutics (NASDAQ:QLGN) Trading Down 3.2%

Qualigen Therapeutics, Inc. stock price. (NASDAQ:QLGN – Get Free Report ) traded down 3.2% during mid-day trading on Thursday. The company traded as low as $0.19 and last traded at $0.20. 259,416 shares traded hands during mid-day trading, down 95% from the session’s average volume of 5,153,807 shares. Shares previously closed at $0.20.

Qualigen Therapeutics Price Performance

The company has a 50-day simple moving average of $0.22 and a 200-day simple moving average of $0.32.

Qualigen Therapeutics (NASDAQ:QLGN – Get Your Free Report ) last issued its earnings results on Tuesday, July 2nd. The company reported ($0.35) earnings per share for the quarter.

About Qualigen Therapeutics

(Get a free report)

Qualigen Therapeutics, Inc, a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. Offers FastPack, a patent-protected rapid immunoassay system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide drug candidate for the treatment of various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases such as COVID-19; RAS-F, a small-molecule oncogenic RAS protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device for removing circulating tumor cells, viruses, inflammatory factors and immune checkpoints.

Featured stories

Get news and reviews for Qualigen Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Qualigen Therapeutics and related companies with MarketBeat.com’s FREE daily email newsletter.